Severe Anemia Treatment Trials, Pakistan

PHASE3CompletedINTERVENTIONAL
Enrollment

1,009

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Anemia
Interventions
DIETARY_SUPPLEMENT

Iron-folic acid and mebendazole

"100 mg iron for pregnant women, 25 mg iron for children~1 mg of folic acid for pregnant women, 100 ug folic acid for children 500 mg of mebendazole for both pregnant women and children"

DRUG

Mebendazole

100 mg twice a day for 3 days; Iron-folic acid also given

DIETARY_SUPPLEMENT

Multivitamins

Iron-folic acid also given; Includes vitamins A, C, B12, E, and B2

DRUG

Mebendazole + Multivitamin

Multivitamins + Mebendazole at 100 mg twice a day for 3 days; Iron-folic acid also given

Trial Locations (1)

Unknown

Aga Khan University, Karachi

All Listed Sponsors
collaborator

Aga Khan University

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT00116493 - Severe Anemia Treatment Trials, Pakistan | Biotech Hunter | Biotech Hunter